Furthermore, gene sets related to NSCLC and broader cancer-related pathways were remarkably enriched in patients with PYCR1up NSCLC (Supplementary Fig. 2n, o), providing strong evidence for the association between elevated PYCR1 expression and lung cancer progression. This evidence concerns the gene PYCR1 and lung cancer.